Columbia University Irving Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high yield challenging scenarios in the management of AL Amyloidosis. Through a combination of lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice.
Learning Objectives
- Clinical presentation, diagnostic methods and risk stratification of patients with newly diagnosed systemic AL Amyloidosis.
- Management of patients with newly diagnosed systemic AL Amyloidosis.
- Management of various organ involvement such as heart failure and nephrotic syndrome, autonomic neuropathy and GI involvement in patients with AL Amyloidosis.
- Discuss and develop consensus in guidelines for managing relapsed and refractory cases, including the role of salvage therapies and experimental approaches.
